Medivir AB (publ)
MVRBF · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $429,212 | $432,714 | $512,469 | $470,930 |
| - Cash | $6,448 | $7,000 | $4,600 | $4,800 |
| + Debt | $15,512 | $0 | $0 | $0 |
| Enterprise Value | $438,276 | $425,714 | $507,869 | $466,130 |
| Revenue | $2,308 | $1,100 | $500 | $500 |
| % Growth | 109.8% | 120% | 0% | – |
| Gross Profit | $2,308 | $1,100 | $500 | $500 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$18,366 | -$14,000 | -$21,400 | -$31,400 |
| % Margin | -795.8% | -1,272.7% | -4,280% | -6,280% |
| Net Income | -$18,065 | -$14,800 | -$23,100 | -$32,700 |
| % Margin | -782.7% | -1,345.5% | -4,620% | -6,540% |
| EPS Diluted | -0.32 | -0.27 | -0.41 | -0.59 |
| % Growth | -18.5% | 34.1% | 30.5% | – |
| Operating Cash Flow | -$24,720 | -$19,700 | -$17,600 | -$39,900 |
| Capital Expenditures | $0 | -$400 | $0 | $0 |
| Free Cash Flow | -$24,720 | -$20,100 | -$17,600 | -$39,900 |